109 related articles for article (PubMed ID: 3017632)
1. Pharmacologic modulation by prostaglandin E1 of superoxide anion production by human polymorphonuclear leukocytes.
Zimmerman JJ
Crit Care Med; 1986 Sep; 14(9):761-7. PubMed ID: 3017632
[TBL] [Abstract][Full Text] [Related]
2. In vitro modulation of human neutrophil superoxide anion generation by various calcium channel antagonists used in ischemia-reperfusion resuscitation.
Zimmerman JJ; Zuk SM; Millard JR
Biochem Pharmacol; 1989 Oct; 38(20):3601-10. PubMed ID: 2554927
[TBL] [Abstract][Full Text] [Related]
3. Concomitant use of prostaglandin E1 and prednisolone; inhibition of superoxide anion production by polymorphonuclear leucocytes.
Miyata M; Ajima H; Kondo Y; Kanno T; Ito M; Nakahata N; Kasukawa R
Fukushima J Med Sci; 1995 Jun; 41(1):15-28. PubMed ID: 8606039
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E and analogs of prostacyclin influencing superoxide production by the human neutrophil NADPH oxidase system.
Umeki S
Int J Biochem; 1994 Aug; 26(8):1003-8. PubMed ID: 8088410
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E1 inhibits N-formyl-methionyl-leucyl-phenylalanine-mediated depolarization responses by decreasing the proportion of responsive cells without affecting chemotaxin-induced forward light scatter changes.
Fletcher MP
J Immunol; 1987 Dec; 139(12):4167-73. PubMed ID: 3693900
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1 attenuates cytotoxic mechanisms of primed neutrophils.
Tamura DY; Moore EE; Partrick DA; Johnson JL; Offner PJ; Silliman CC
Shock; 1998 Mar; 9(3):171-6. PubMed ID: 9525323
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by reactive aldehydes of superoxide anion radical production from stimulated polymorphonuclear leukocytes and pulmonary alveolar macrophages. Effects on cellular sulfhydryl groups and NADPH oxidase activity.
Witz G; Lawrie NJ; Amoruso MA; Goldstein BD
Biochem Pharmacol; 1987 Mar; 36(5):721-6. PubMed ID: 3030333
[TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibition of human polymorphonuclear function by prostaglandin E1 and linsidomine.
Gladis-Villanueva M; Schrör K
J Pharm Pharmacol; 1996 Jul; 48(7):706-11. PubMed ID: 8866334
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin stimulates phosphoinositide turnover and phospholipase C but not phospholipase D and NADPH oxidase in human neutrophils.
Catz SD; Steŕin-Speziale NB
J Leukoc Biol; 1996 Apr; 59(4):591-7. PubMed ID: 8613709
[TBL] [Abstract][Full Text] [Related]
10. PMN superoxide radical production following a metabolic-endocrine simulation of trauma.
Moon BC; Girotti MJ; Dawson R; Wren SF
Ann Surg; 1986 Mar; 203(3):246-9. PubMed ID: 3006614
[TBL] [Abstract][Full Text] [Related]
11. H2-antagonist inhibition of human neutrophil superoxide anion synthesis.
Zimmerman J; Millard J
Clin Pharmacol Ther; 1989 May; 45(5):487-94. PubMed ID: 2541961
[TBL] [Abstract][Full Text] [Related]
12. Examination of the enzyme assay for NADPH oxidoreductase; application to polymorphonuclear leukocyte superoxide anion generation.
Zimmerman JJ; Shelhamer JH; Parrillo JE
Crit Care Med; 1985 Mar; 13(3):197-203. PubMed ID: 2982545
[TBL] [Abstract][Full Text] [Related]
13. Effects of a 5-lipoxygenase inhibitor, AA861, on lipoxygenase metabolism and superoxide anion generation by human polymorphonuclear leukocytes--potentiation of superoxide anion generation by LTB4.
Tanaka K; Abe M; Shigematsu N
Int Arch Allergy Immunol; 1992; 98(4):361-9. PubMed ID: 1330136
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil.
Fantone JC; Marasco WA; Elgas LJ; Ward PA
J Immunol; 1983 Apr; 130(4):1495-7. PubMed ID: 6300229
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of non-steroidal anti-inflammatory drugs on superoxide generation.
Yuda Y; Tanaka J; Suzuki K; Igarashi K; Satoh T
Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):1075-7. PubMed ID: 1654219
[TBL] [Abstract][Full Text] [Related]
16. Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro.
Farmer JC; Burkey TH; Kew RR; Webster RO
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):593-9. PubMed ID: 1654039
[TBL] [Abstract][Full Text] [Related]
17. Activated neutrophils inhibit Na(+)-K(+)-ATPase in canine renal basolateral membrane.
Julin CM; Zimmerman JJ; Sundaram V; Chobanian MC
Am J Physiol; 1992 Jun; 262(6 Pt 1):C1364-70. PubMed ID: 1319673
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prostaglandin E1 for prevention of respiratory failure in high risk trauma patients: a prospective clinical trial and correlation with plasma suppressive factors for neutrophil activation.
Vassar MJ; Fletcher MP; Perry CA; Holcroft JW
Prostaglandins Leukot Essent Fatty Acids; 1991 Dec; 44(4):223-31. PubMed ID: 1667693
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils.
Fantone JC; Kinnes DA
Biochem Biophys Res Commun; 1983 Jun; 113(2):506-12. PubMed ID: 6307290
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of prostaglandin E1 on human neutrophil function.
Mikawa K; Akamatsu H; Maekawa N; Nishina K; Obara H; Niwa Y
Prostaglandins Leukot Essent Fatty Acids; 1994 Oct; 51(4):287-91. PubMed ID: 7846097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
